Trial
NCT05521880
Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Substance Use Disorders
Intervention
Oritavancin
Why stopped
The study was not able to enroll adequate participants within predetermined timelines
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29